Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
Awards
CRO Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
Awards
CRO Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
U.S. Federal Trade Commission
Pharma
Teva moves to delist 200-plus patents from FDA registry: FTC
Teva has asked the FDA to remove hundreds of patents from its registry, according to the FTC.
Eric Sagonowsky
Dec 10, 2025 4:58pm
Fierce Biotech
Pfizer finalizes Metsera buy after contentious Novo bidding war
Nov 13, 2025 12:43pm
Fierce Biotech
FTC tells Novo that Metsera offer may violate US merger law
Nov 5, 2025 4:26pm
Trump's nominee to chair the FTC could bode well for pharma M&A
Dec 11, 2024 11:25am
Biopharma status quo likely to persist under Trump 2.0: analyst
Nov 21, 2024 1:15pm
Roche CEO critiques Novo's proposed Catalent buyout
Oct 23, 2024 12:35pm